Numerous studies have consistently illustrated that PSMA exhibits superior sensitivity and specificity compared to traditional approaches or choline PET, particularly in identifying tumor recurrence, especially in patients with low PSA levels (<1.0 ng/mL) [9]. Here, FOLH1 is linked to neoplasm.